ABSTRACT
Pulmonary complications are an important source of morbidity and mortality
among HIV-infected individuals. While Pneumocysitis jiroveci pneumonia
represented the most important pulmonary complication through the mid-1990s,
the spectrum of pulmonary complications associated with HIV has changed with
the advent of highly active antiretroviral therapy (HAART) and improved
therapy for HIV (1). With the aging of the HIV population, the spectrum of
pulmonary diseases causing important morbidity and mortality continues to
evolve. Lung diseases associated with aging, such as chronic obstructive pul-
monary disease (COPD) and bronchogenic cancer, appear to be more common in
the HIV-seropositive population and will likely become more prevalent as this
population ages, particularly given the high prevalence of cigarette smoking
among HIV-infected individuals.
